Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01362374
Title Safety and Pharmacology Of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech
Indications

Advanced Solid Tumor

Therapies

Enzalutamide

Paclitaxel

Docetaxel

Ipatasertib

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA | FRA | ESP


No variant requirements are available.